ArticleBMC gastroenterology2026
Interpretable model for early prediction of 28-day mortality in patients with cirrhosis and sepsis: a multi-cohort ICU study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirrhosis complicated by sepsis is a common reason for intensive care unit (ICU) admission and is associated with a markedly increased risk of short-term mortality. However, early assessment of 28-day mortality risk at ICU admission remains uncertain in this population. Existing scoring systems often rely on subjective assessments or clinical variables that may not be readily available at the time of admission, highlighting the need for a simple and objective model based on routinely obtainable data for early risk stratification.
methodsData from the Medical Information Mart for Intensive Care (MIMIC)-IV database were used for model development and internal validation, while MIMIC-III and the multicenter eICU Collaborative Research Database (eICU) were used for external validation. Predictors were selected using least absolute shrinkage and selection operator regression combined with Boruta feature selection and clinical judgment. Multiple machine learning algorithms were compared, and logistic regression was selected as the final model.
resultsIn the MIMIC-IV cohort, 3,670 patients were screened, of whom 1,615 met the inclusion criteria and were used for model development and internal validation. External validation included 207 patients from MIMIC-III and an additional multicenter cohort from eICU. Six predictors were retained: age, white blood cell count, total bilirubin, glucose, international normalized ratio, and lactate. In internal validation, the logistic regression model achieved an area under the receiver operating characteristic curve (AUROC) of 0.785 (95% CI 0.741–0.830), outperforming SOFA 0.671 (95% CI 0.617–0.725) and MELD 0.728 (95% CI 0.679–0.777). In the MIMIC-III external validation cohort, the AUROC was 0.756 (95% CI 0.690–0.821), compared with 0.663 (95% CI 0.588–0.737) for SOFA and 0.731 (95% CI 0.663–0.799) for MELD. In the multicenter eICU cohort, the model demonstrated an AUROC of 0.745 (95% CI 0.657–0.833).
conclusionsA logistic regression model based on six routinely available variables within the first 24 h of ICU admission demonstrated stable discriminative performance for predicting 28-day mortality in patients with cirrhosis and sepsis. The model provides a simple and objective tool to support early mortality risk stratification at ICU admission in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.